Q: thoughts on earnings
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What do you think now of Valiant Pharmaceuticals?
It is at its lowest 52 week low. Its market cap is still 5.35 Billion.
Is it recommended for a buy and hold for at least a year?
It is at its lowest 52 week low. Its market cap is still 5.35 Billion.
Is it recommended for a buy and hold for at least a year?
Q: Mr. Hodson, I appreciate your response to Stephen today regarding GUD. When do you expect the weakness to stop ?
Q: Any explanation for GUD's weakness the past couple of days?
Q: I've enjoyed a quick run-up on TH. It now represents an 8% portfolio weight. My questions is two parts. First, could you comment on their prospects? Their earnings should be growing and they are adding a drug to their offering. As a thing trader, there could be a big run-up as the story gains traction.
Second, in a case like this where there is a quick run-up and the portfolio weighting becomes large, when is it time to trim? It seems to me that using portfolio weight as your only guide could mean missing big gains if you're early on a good company.
Second, in a case like this where there is a quick run-up and the portfolio weighting becomes large, when is it time to trim? It seems to me that using portfolio weight as your only guide could mean missing big gains if you're early on a good company.
Q: Hello. How does the 5I team rate the quality of the management of PLI? Has PLI also given any indication of product releases for 2017 given that their drug tests favourably in all tests and has orphan drug status?
Thank You
Clarence
Thank You
Clarence
Q: Guys, great site, great job. Can you comment on CVR Medical Corp.
Q: Hi,Any insights here. Looks like they may be on to something.
Thanks
G
Thanks
G
Q: Thinking of this one in replacement of GILD that i sold 2 weeks ago. low p/e and peg, nice dividend but high debt.Argus and S&P by applying comp p/e come up with a target of 84$. Does it deserve the p/e or cheap for a reason?
What is your view on this one ?
Any suggestion ?
(like everybody else: I know you don't cover US stocks... bla bla bla)
Thanks much!
What is your view on this one ?
Any suggestion ?
(like everybody else: I know you don't cover US stocks... bla bla bla)
Thanks much!
Q: I was asked to review my sons portfolio and he is a ETF investor mainly. I have a concern with the very high MER of 3.76% current for healthcare Leader income ETF It has a high yield (8.4%) that I think is tempting him but Brand leader fund by the same firm has a mer of 1.44 %. Why the big difference. I see the hhl is advertised and promoted heavily on BNN. Are they charging fund holders for their promo on a under preforming fund? I found a great site The Wealth Game (wealthgame.ca) that lets you calculate the true cost over time of fees. It can be an eye opener for younger people with longer time horizons that are sucked into what they may think are low fees such as 2 or 3 percent. Your views please.
Q: Savaria coming out with earnings next week. Do you think we will get some news
Q: I am looking for US Healthcare ETF. What do you recommend?
Q: What do you think of KERX? Thanks.
Q: Hi 5i,
The after hours trading (Feb 28th) on SRPT was ugly following their report. A big miss on expectations but they were expected to lose money and I can’t tell what the expectations themselves might have been based on. I know you may not be overly familiar, as it is a US stock, but can you help size it up? I'm wondering if it is real trouble or maybe an over-reaction opportunity once things settle down a bit. Thanks!
The after hours trading (Feb 28th) on SRPT was ugly following their report. A big miss on expectations but they were expected to lose money and I can’t tell what the expectations themselves might have been based on. I know you may not be overly familiar, as it is a US stock, but can you help size it up? I'm wondering if it is real trouble or maybe an over-reaction opportunity once things settle down a bit. Thanks!
Q: hi Guys,
Can I please get your opinion of Extendicare's latest results.
Thanks
Dave
Can I please get your opinion of Extendicare's latest results.
Thanks
Dave
Q: For a little penny stock fun, I purchased Medx Health last year for 12 cents. It went well into 20's, but has now retreated to 12. would very much appreciate your professional review/assessment
Q: Hi 5i,
Looking to add a specialty pharmaceutical with growth potential in a TFSA. Willing to wait for the growth and am comfortable with the risk. Morningstar rates both of these as 'undervalued' currently. Which do you prefer for future growth prospects? Thank-you.
Looking to add a specialty pharmaceutical with growth potential in a TFSA. Willing to wait for the growth and am comfortable with the risk. Morningstar rates both of these as 'undervalued' currently. Which do you prefer for future growth prospects? Thank-you.
Q: Hi, Savaria price has declined sharply over last 3 trading sessions on large volume. Any insight/comments ? Thanks
Q: You state that the stock is cheap based on certain metrics.Please elaborate.
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH)
-
Harvest Healthcare Leaders Income ETF (HHL)
Q: What is your opinion on HHL